FDA Approves Keytruda for Cancers with Specific BiomarkerByBioPharm InternationalMay 26th 2017Pharmaceutical Executive
EMA Launches Biosimilars ProjectByBioPharm InternationalDecember 20th 2016Pharmaceutical ExecutiveDecember 20, 2016
HHS Awards $8.2 Million to Moderna for Zika Vaccine DevelopmentByBioPharm InternationalSeptember 9th 2016Pharmaceutical ExecutiveSeptember 9, 2016
Pfizer to Acquire MedivationByBioPharm InternationalAugust 22nd 2016Pharmaceutical ExecutiveAugust 23, 2016
NIH Launches Zika Vaccine Clinical TrialByBioPharm InternationalAugust 5th 2016Pharmaceutical ExecutiveAugust 05, 2016
Shire Announces $400 Million Ireland InvestmentByBioPharm InternationalApril 18th 2016Pharmaceutical ExecutiveApril 18, 2016.
FDA's New Quality Metrics Address Industry ConcernsByBioPharm InternationalNovember 24th 2015Pharmaceutical ExecutiveNovember 24, 2015.